Global Health Limited
Bookbuilding IPO · NSE, BSE
- Price band
- ₹336 - ₹336
- Lot size
- 44 shares
- Issue amount
- ₹2,205.57 cr
- Total subscription
- 9.58×
- Opens
- 3 Nov 2022
- Closes
- 7 Nov 2022
- Allotment
- 11 Nov 2022
- Listing
- 16 Nov 2022
Offer at a glance
Issue overview
- Issue size
- 6,56,41,952 shares
- Face value
- ₹2 Per Share
- Minimum investment
- ₹14,784
- Fresh issue
- ₹500 cr
- Offer for sale
- ₹1,705.57 cr
- Registrar
- Kfin Technologies Limited
- Listing exchange
- NSE, BSE
- Maximum investment
- ₹14,784
- Issue type
- Bookbuilding IPO
- Shares before issue
- 25,33,03,930
- Shares after issue
- 26,81,84,882
Lot sizes
| Category | Lots | Shares | Amount |
|---|---|---|---|
| RETAIL | 1 | 44 | ₹14,784 |
| sHNI | 14 | 616 | ₹2,06,976 |
| bHNI | 68 | 2,992 | ₹10,05,312 |
Share reservation
Subscription & GMP
Subscription by category
Subscription figures are awaiting publication.
GMP history
Financial performance
Company financials
In Crores · Reported periods may include interim results.
Company information
Company profile
Global Health Limited is one of the largest private multi-speciality tertiary care providers in North and East India, operating under the "Medanta" brand. The company specializes in cardiology, neurosciences, oncology, digestive sciences, orthopaedics, liver transplants, and kidney care. With hospitals in Gurugram, Indore, Ranchi, and Lucknow, it offers healthcare services across 30 medical specialities with over 1,300 doctors and 2,467 installed beds. Medanta’s Gurugram hospital was ranked India’s best private hospital from 2020 to 2022 and featured in Newsweek’s global hospital rankings. The company emphasizes clinical research, academic excellence, and advanced medical infrastructure. Its strong financial performance, presence in high-demand areas, and expansion into digital health contribute to its growth. Backed by experienced management and institutional investors, Global Health Limited continues to strengthen its position in India's healthcare sector.
Promoters
Dr. Naresh Trehan
Registrar & documents
Lead manager
Kotak Mahindra Capital Company, Credit Suisse Securities (India) Private Limited, Jefferies India Private Limited, Jm Financial Limited
Registrar & contacts
Kfin Technologies Limited
[email protected]Official registrar portal ↗Check allotment status on registrar →Registered office
Medanta – Mediclinic, E-18, Defence Colony, New Delhi, Delhi 110 024,
+91 124 483 4060
[email protected]Company website ↗Frequently Asked Questions
What is Global Health IPO GMP today?
As of today, Global Health IPO Grey Market Premium (GMP) is reported at +₹33 per share. Based on the upper price band of ₹336, the estimated listing price is ₹369 (+9.8% expected listing gain). Please note that GMP is an unofficial market estimate for sentiment tracking and does not guarantee the actual listing price.
What is the lot size and minimum investment for Global Health IPO?
The minimum bid lot size for Global Health IPO is 44 shares. At the cut-off price of ₹336 per share, retail investors need a minimum application amount of ₹14,784 per lot. Retail applicants can apply for a maximum of 13 lots (up to ₹2,00,000).
When will Global Health IPO allotment status be announced?
The allotment status for Global Health IPO is scheduled to be finalized on 11 Nov 2022. If you applied for the IPO, you can verify whether shares have been allocated to your Demat account through Kfin Technologies Limited's official portal or via BSE/NSE allotment portals.
How can I check Global Health IPO allotment status online by PAN?
To check Global Health IPO allotment status: 1) Visit the registrar portal (Kfin Technologies Limited) or the BSE IPO allotment page. 2) Select 'Global Health Limited' from the company dropdown. 3) Choose 'PAN' as your identification mode and enter your 10-digit Permanent Account Number. 4) Click 'Search' to view your allotted share quantity and application status.
Explore More IPO Analysis & Live Tools
Compare the price band and required investment with company financials and official offer documents. Grey market premium (GMP) figures are indicative market estimates collected from primary market brokers and do not establish the official listing price.